Smoking-Related DNA Methylation is Associated with DNA Methylation Phenotypic Age Acceleration: The Veterans Affairs Normative Aging Study

DNA methylation may play a critical role in aging and age-related diseases. DNA methylation phenotypic age (DNAmPhenoAge) is a new aging biomarker and predictor of chronic disease risk. While smoking is a strong risk factor for chronic diseases and influences methylation, its influence on DNAmPhenoAge is unknown. We investigated associations of self-reported and epigenetic smoking indicators with DNAmPhenoAge acceleration in a longitudinal aging study in eastern Massachusetts. DNA methylation was measured in whole blood samples from multiple visits for 692 male participants in the Veterans Affairs Normative Aging Study during 1999–2013. Acceleration was defined using residuals from linear regression of the DNAmPhenoAge on the chronological age. Cumulative smoking (pack-years) was significantly associated with DNAmPhenoAge acceleration, whereas self-reported smoking status was not. We observed significant validated associations between smoking-related loci and DNAmPhenoAge acceleration for 52 CpG sites, where 18 were hypomethylated and 34 were hypermethylated, mapped to 16 genes. The AHRR gene had the most loci (N = 8) among the 16 genes. We generated a smoking aging index based on these 52 loci, which showed positive significant associations with DNAmPhenoAge acceleration. These epigenetic biomarkers may help to predict age-related risks driven by smoking.

[1]  M. Levine,et al.  An epigenetic biomarker of aging for lifespan and healthspan , 2018, bioRxiv.

[2]  Paola Sebastiani,et al.  Biomarker signatures of aging , 2017, Aging cell.

[3]  H. Brenner,et al.  Relationship of tobacco smoking and smoking-related DNA methylation with epigenetic age acceleration , 2016, Oncotarget.

[4]  C. Ladd-Acosta,et al.  The role of epigenetics in genetic and environmental epidemiology. , 2016, Epigenomics.

[5]  S. Beach,et al.  Methylomic Aging as a Window onto the Influence of Lifestyle: Tobacco and Alcohol Use Alter the Rate of Biological Aging , 2015, Journal of the American Geriatrics Society.

[6]  H. Brenner,et al.  DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies , 2015, Clinical Epigenetics.

[7]  S. Beach,et al.  Current and Future Prospects for Epigenetic Biomarkers of Substance Use Disorders , 2015, Genes.

[8]  A. Brunet,et al.  Epigenetic regulation of ageing: linking environmental inputs to genomic stability , 2015, Nature Reviews Molecular Cell Biology.

[9]  D. Belsky,et al.  Quantification of biological aging in young adults , 2015, Proceedings of the National Academy of Sciences.

[10]  A. Teschendorff,et al.  Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer. , 2015, JAMA oncology.

[11]  H. Brenner,et al.  Smoking-Associated DNA Methylation Biomarkers and Their Predictive Value for All-Cause and Cardiovascular Mortality , 2015, Environmental health perspectives.

[12]  M. Kobor,et al.  DNA methylation and healthy human aging , 2015, Aging cell.

[13]  L. Bernstein,et al.  Associations of Mortality with Long-Term Exposures to Fine and Ultrafine Particles, Species and Sources: Results from the California Teachers Study Cohort , 2015, Environmental health perspectives.

[14]  Å. Johansson,et al.  Smoke-related DNA methylation changes in the etiology of human disease. , 2014, Human molecular genetics.

[15]  M. Fallin,et al.  Epigenetic epidemiology: Promises for public health research , 2014, Environmental and molecular mutagenesis.

[16]  Thomas W. Mühleisen,et al.  Aging of blood can be tracked by DNA methylation changes at just three CpG sites , 2014, Genome Biology.

[17]  W. McArdle,et al.  Differences in smoking associated DNA methylation patterns in South Asians and Europeans , 2014, Clinical Epigenetics.

[18]  S. Beach,et al.  Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking , 2013, Clinical Epigenetics.

[19]  S. Horvath.  DNA methylation age of human tissues and cell types , 2013, Genome Biology.

[20]  Zdenka Pausova,et al.  Cigarette smoking and DNA methylation , 2013, Front. Genet..

[21]  M. Levine.  Modeling the rate of senescence: can estimated biological age predict mortality more accurately than chronological age? , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[22]  Guoyin Feng,et al.  CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population , 2013, Psychiatry Research.

[23]  L. Gordon,et al.  Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance , 2013, Genome Biology.

[24]  Christian Gieger,et al.  Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation , 2013, PloS one.

[25]  Paolo Vineis,et al.  Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. , 2013, Human molecular genetics.

[26]  T. Ideker,et al.  Genome-wide methylation profiles reveal quantitative views of human aging rates. , 2013, Molecular cell.

[27]  H. Brenner,et al.  Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. , 2012, European heart journal.

[28]  Devin C. Koestler,et al.  DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.

[29]  Robert A Philibert,et al.  Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  M. Kyba,et al.  Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells. , 2011, Blood.

[31]  Luigi Ferrucci,et al.  Frailty as a Nexus Between the Biology of Aging, Environmental Conditions and Clinical Geriatrics , 2010 .

[32]  M. Dąbrowski,et al.  Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2 , 2009, Inflammation Research.

[33]  L. Groop,et al.  Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus , 2008, Nature Genetics.

[34]  J A Veltman,et al.  CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy , 2008, Molecular Psychiatry.

[35]  J. Sebat,et al.  Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. , 2008, American journal of human genetics.

[36]  Muin J Khoury,et al.  The role of genetic polymorphisms in environmental health. , 2003, Environmental health perspectives.

[37]  H. Autrup.  Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. , 2000, Mutation research.

[38]  B. Bell,et al.  The Veterans Administration longitudinal study of healthy aging. , 1966, The Gerontologist.

[39]  Huang,et al.  Preparation of rabbit anti-rat LRRN3 polyclonal antibody and study of its expression , 2010 .

[40]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .